Blog · corpus.blog/blogs/statnews.com/posts
STAT News
statnews.com
2026
24 Sept 2026
STAT+: In radiology, AI is blurring the line between technology development and clinical practiceoriginal ↗
24 Sept 2026
STAT+: Trump boast on drug pricing policy overstated state-level interest in federal programoriginal ↗
24 Sept 2026
24 Sept 2026
24 Sept 2026
Opinion: STAT+: A moment of reckoning for preventive cardiology and the precision medicine revolutionoriginal ↗
24 Sept 2026
23 Sept 2026
STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risksoriginal ↗
23 Sept 2026
23 Sept 2026
STAT+: Pharmalittle: We’re reading about a closing loophole for importing meds, European competitiveness, and moreoriginal ↗
23 Sept 2026
23 Sept 2026
23 Sept 2026
STAT+: A private equity-owned hospital chain is becoming a nonprofit. Is it just a bailout for investors?original ↗
23 Sept 2026
22 Sept 2026
Opinion: Social media bans are passing around the world. How will we know if they help teens?original ↗
22 Sept 2026
22 Sept 2026
STAT+: Members of Congress push back on plan to create a commission of political appointees to review NIH grantsoriginal ↗
21 Sept 2026
STAT+: What a vote on Grail’s cancer detection test could mean for the company, patients, and regulatorsoriginal ↗
21 Sept 2026
STAT+: Pharmalittle: We’re reading about Novo plans to expand its pipeline, early Alkermes ADHD data, and moreoriginal ↗
21 Sept 2026
21 Sept 2026
21 Sept 2026
21 Sept 2026
19 Sept 2026
18 Sept 2026
18 Sept 2026
STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and moreoriginal ↗
18 Sept 2026
18 Sept 2026
Opinion: More young men are coming to me for plastic surgery. The way I think about them has changedoriginal ↗
18 Sept 2026
18 Sept 2026
17 Sept 2026
STAT+: Why do ‘never-smokers’ get lung cancer? In some cases, rare genetic variant may be a factororiginal ↗
17 Sept 2026
Kennedy moves to revive preventive services panel with new members, after months of vacanciesoriginal ↗
17 Sept 2026
STAT+: Pharmalittle: We’re reading about FDA hiring delays, a new Bavarian Nordic CEO, and moreoriginal ↗
17 Sept 2026
STAT+: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing dealoriginal ↗
17 Sept 2026
STAT+: GOP aims to change Medicare adviser’s math so it’s more favorable to health insurersoriginal ↗
16 Sept 2026
16 Sept 2026
16 Sept 2026
STAT+: Sen. Warren demands to see Trump drug-pricing pharma contracts, accuses RFK Jr. of hiding themoriginal ↗
16 Sept 2026
STAT+: Pharmalittle: We’re reading about faster FDA approvals, access to experimental drugs in Montana, and moreoriginal ↗
16 Sept 2026
16 Sept 2026
15 Sept 2026
15 Sept 2026
STAT+: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and moreoriginal ↗
15 Sept 2026
15 Sept 2026
15 Sept 2026
STAT+: Medicare’s AI prior authorization pilot was rushed and full of problems, new documents revealoriginal ↗
15 Sept 2026
15 Sept 2026
14 Sept 2026
14 Sept 2026
STAT+: Pharmalittle: We’re reading about another AstraZeneca trial failure, a Novo name change, and moreoriginal ↗
14 Sept 2026
14 Sept 2026
14 Sept 2026